Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

NCT03757650 is registered in ClinicalTrials.gov with Fatih Sultan Mehmet Training and Research Hospital as lead sponsor.

NCT NCT03757650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY
Lead sponsor
Fatih Sultan Mehmet Training and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2018
Completion date
February 1, 2021
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection, obesity, morbid